5Chimowitz M I, Lynn M J, Derdeyn C P, et al. for SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy or intracranial arterial stenosis[J]. N Engl J Med, 2011, 365(11): 993--1003.
6Mori T, Fukuoka M, Kazita K, et al. Follow-up study after in tracranial percutaneous transluminal cerebral balloon angioplasty[J]. AJNR, 1998,19(8) : 1525-- 1533.
7Kasner S E. Chimowitz M I,Lvnn M J,et al. Predictors of ische- mie stroke in the territory of a symptomatic intracranial arterial stenosis[J]. Circulation,2006,113(4) :555-563.
8Higashida R T, Furlan A J, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for a- cute isehemic stroke[J]. Stroke, 2003,34 (8) : el09-- 137.
9Fiorella D J, Levy E I, Turk A S, et al. Target lesion revaseu larization after wingspan: assessment of safety and durability [J]. Stroke,2009,40(1) : 106-- 110.
10Schumacher H C, Meyers P M, Higashida R T, et al. Repor- ting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis[J], J Neurolnterv Surg, 2010, 2(4) : 324--340.
